http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ece75abc4895cc7f9300c8086bf1883f
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Cardoso |
| name | Fatima Cardoso |
| given-name | Fatima |
| organization-name | Otto Metzger-Filho, Dana-Farber Cancer Institute; Zhuoxin Sun, Dana-Farber Cancer Institute, Harvard School of Public Health; Richard D. Gelber, Dana-Farber Cancer Institute, Harvard School of Public Health, Harvard Medical School; Karen N. Price, Frontier Science and Technology Research Foundation, Boston, MA; Giuseppe Viale, European Institute of Oncology and University of Milan; Aron Goldhirsch, European Institute of Oncology, Milan; Diana Crivellari, Centro di Riferimento Oncologico, Aviano, Italy;... European Organisation for Research and Treatment of Cancer, Brussels, Belgium; Breast Unit, Champalimaud Clinical Centre, Champalimaud Foundation, Lisbon, Portugal 2Translational Research Unit,; 5Medical Oncology Unit, Institut J. Bordet, Brussels, Belgium and Champalimaud Foundation, Champalimaud Centre for the Unknown, Lisbon, Portugal Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal. Electronic address: fatimacardoso@fundacaochampalimaud.pt. Jules Bordet Institute, Brussels, Belgium; 12Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal. Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation , Lisbon , Portugal Breast Unit, Champalimaud Clinical Centre, Champalimaud Foundation, Lisbon, Portugal Jules Bordet Institute, Brussels for the TRANSBIG consortium From the Institut Jules Bordet; Machine Learning Group, Université Libre de Bruxelles; Hôpitaux Iris Sud–Site Etterbeek-Ixelles; Hopital Saint-Pierre, Brussels; Clinique Saint-Pierre, Ottignies; Clinique Ste Elisabeth, Namur; International Drug Development Institute, Louvain-La-Neuve, Belgium; Hospital of Prato, Prato, Italy; Institut Gustave Roussy, Villejuif, France; Centre Hospitalier du Luxembourg, Luxembourg, Luxembourg; and University of Texas MD Anderson Cancer Center, Houston, TX. 1Translational Research Unit and Breast Unit, Champalimaud Clinical Center, Champalimaud Foundation, Lisbon, Portugal From the Departments of Breast Medical Oncology, Quantitative Sciences, Surgical Oncology, Pathology, Radiation Oncology, and Systems Biology, The University of Texas M. D. Anderson Cancer Center, Houston, TX; the Departments of Medical Oncology and Translational Research, and Pathology, Jules Bordet Institute, Brussels, Belgium; Department of Gynecology and Obstetrics, General Hospital Leoben, Leoben; and Department of Therapeutic Radiotherapy and Oncology, University Medical School of Graz, Graz, Austria. Champalimaud Clinical Centre/Champalimaud Foundation, Lisbon, Portugal From the University of Washington; Seattle Cancer Care Alliance, Seattle, WA; Clinical Investigations Branch, Division of Cancer Diagnosis and Treatment; Biostatistics Branch, Division of Cancer Epidemiology and Genetics; Division of Cancer Prevention, National Cancer Institute, Bethesda; Emmes Corporation, Rockville, MD; Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA; Karmanos... 1Jules Bordet Institute, Brussels, Belgium; Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal. fatimacardoso@fundacaochampalimaud.pt From the Jules Bordet Institute, Brussels, Belgium; Netherlands Cancer Institute, Amsterdam, the Netherlands; and Peter MacCallum Cancer Centre, Melbourne, Australia Champalimaud Clinical Center/Champalimaud Foundation, Breast Unit, Lisbon, Portugal Breast Unit, Champalimaud Clinical Centre/Champalimaud Foundation, Portugal. Breast Unit Champalimaud Clinical Centre Champalimaud Foundation Lisboa Portugal Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. Jules Bordet Institute, Brussels, Belgium Department of Medical Oncology, Jules Bordet Institute, Brussels, Belgium 3Jules Bordet Institute, Brussels, Belgium; Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal. Affiliations of authors: Department of Medical Oncology, Medical Oncology & Translational Research Unit, Jules Bordet Institute, Brussels, Belgium (FC, PLB); Department of Medical Oncology, Dana-Farber Cancer Institute, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA (EPW); Department of Medical Oncology, Oncology Institute of Southern Switzerland, Ospedale Italiano, Viganello, Lugano (OP); Switzerland Breast Unit, Champalimaud Clinical Center-Champalimaud Foundation, Lisbon, Portugal. John M.S. Bartlett, Ontario Institute for Cancer Research; Frances P. O'Malley, St Michael's Hospital; Kathleen I. Pritchard, Sunnybrook Odette Cancer Centre and University of Toronto, Toronto; John M.S. Bartlett, Frances P. O'Malley, and Lois E. Shepherd, National Cancer Institute of Canada Clinical Trials Group; Lois E. Shepherd, Queen's University, Kingston, Canada; John M.S. Bartlett, Alison F. Munro, and David A. Cameron, University of Edinburgh, Edinburgh; Christopher C. McConkey, Janet A. Dunn,... Breast Unit Champalimaud Clinical Center/Champalimaud Foundation Lisbon Portugal Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal From the Indiana University Simon Cancer Center, Indianapolis, IN; Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal; Dana-Farber Cancer Institute, Boston, MA; Institut Jules Bordet, Université Libre de Bruxelles, Belgium. Department of Medical Oncology, Institut Jules Bordet, Brussels, Belgium. fatima.cardoso@bordet.be From Champalimaud Clinical Center-Champalimaud Foundation, Lisbon, Portugal (F.C.); Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (L.J.V.); European Organization for Research and Treatment of Cancer Headquarters (J.B., L. Slaets, V.G., B.M., K.T.), Breast International Group Headquarters (T.G., C. Straehle), and Institut Jules Bordet, Université Libre de Bruxelles (C. Sotiriou, M.P.), Brussels, and Centre Hospitalier Universitaire Université Catholique de Louvain, Namur (P.V.) - both in Belgium; University of Milan and Istituto Europeo di Oncologia (G.V.) and Europa Donna-European Breast Cancer Coalition (S.K.), Milan, and Azienda Istituti Ospitalieri di Cremona, Cremona (R.P.) - both in Italy; Gustave Roussy, Villejuif (S.D., M.S.), Institut Curie Paris Sciences et Lettres, Université Paris Descartes, Sorbonne Paris Cité, Paris (J.-Y.P.). Institut Curie-Hôpital Rene Huguenin, Saint-Cloud (E.B.), and Centre Georges-Francois-Leclerc, Dijon (S.C.) - all in France; Swiss Institute of Bioinformatics and University of Lausanne, Lausanne, Switzerland (M.D.); Agendia (A.M.G., L. Stork) and the Netherlands Cancer Institute (R.B., E.R.), Amsterdam, Alrijne Ziekenhuis, Rijnland Leiderdorp (P.A.N.), Jeroen Bosch Hospital, 's-Hertogenbosch (T.J.S.), and Medisch Centrum Alkmaar, Alkmaar (J.M.H.) - all in the Netherlands; Institute of Oncology, Ljubljana, Slovenia (E.M.); Evangelisches Krankenhaus Bethesda, Duisburg, Germany (U.N.); University of Texas Health Sciences Center, San Antonio (P.R.); Hospital Universitario Vall d'Hebron, Barcelona (I.T.R.); Imperial College London, London (G.T.); and University of Texas M.D. Anderson Cancer Center, Houston (A.M.T.). From the Department of Medical Oncology, Institute of Oncology, Ljubljana, Slovenia; Breast Unit, Champalimaud Cancer Center, Champalimaud Foundation, Lisbon, Portugal. Breast Unit Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal 1Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium; b Medical Oncology Clinic, Jules Bordet Institute, Brussels, Belgium Champalimaud Cancer Center, Lisbon, Portugal. From the Nottingham City Hospital, Nottingham; Royal Marsden Hospital, London, United Kingdom; Innere Klinik und Poliklinik (Tumorforschung), Universitätsklinikum Essen, Essen; Frauenklinik Rotes Kreuz, Munich; Klinik für Tumorbiologie, Freiburg; Stadtische Kliniken Oldenburg, Oldenburg; Albert Ludwigs-Universität Freiburg, Freiburg, Germany; Institut Jules Bordet, Brussels, Belgium; Ludwig Boltzmann-Institute for Applied Cancer Research, Kaiser-Franz-Josef-Spital, Vienna, Austria; Kantonsspital St.... Breast Unit Champalimaud Clinical Centre/Champalimaud Foundation Lisboa Portugal |
Incoming Links
Total number of triples: 237.